Abbott | ABT - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.6B 330M 2026-06
Agilent USD 465M 11M 2026-03
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio-Rad Laboratories USD 212.4M 8.6M 2026-03
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Danaher USD 2.07B 212M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Globus Medical USD 297.77M 20.7M 2026-03
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Pfizer USD 3.41B 496M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06
Solventum Corp USD 783M 24M 2026-03
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Terumo JPY 114.81B 9.55B 2026-03
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03